Crossmark

Duration of adjuvant immunotherapy—biologic, clinical and economic considerations

Crossref DOI link: https://doi.org/10.1007/s12032-018-1218-0

Published Online: 2018-10-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stav, Ido

Gyawali, Bishal

Goldstein, Daniel A. https://orcid.org/0000-0002-8082-9622
License Information

Text and Data Mining valid from 2018-10-29
More Information

Article History

Received: 23 July 2018

Accepted: 24 October 2018

First Online: 29 October 2018

Compliance with ethical standards

:

: The authors declare that they have no competing interests.

: No ethics approval was required as this was an economic analysis without human subjects.